Exosomes – News and Features

Research suggests that exosomes alone could protect infants' lungs from dangerous inflammation.

Leading UK scientist, Dr Andrew Shuttleworth, joins NanoSight board as Director of Diagnostic Sciences.

Exosome Diagnostics to use the Applied Biosystems® (ABI) 7500 Fast Dx Real-Time PCR Instrument for the Company's exosome biofluid in-vitro diagnostics oncology program.

Partnership aims to advance clinical studies of Exosome biofluid molecular diagnostics technology in brain cancer.

File joint patent application for new peptides that support targeted diagnosis and therapies.

New RNA biofluid diagnostics for the detection, progression monitoring, and advanced disease risk stratification in prostate cancer.

Latest webinar aimed at those with a similar interest in the detection and speciation of exosomes and micro-vesicles.

Conference is designed to bring together researchers in the rapidly growing field of exosomes and microvesicles.

NanoSight reports the new publication in one of the most cited peer reviewed journals in nanoscience and nanotechnology, NanoMedicine.

In this paper researchers from the German Cancer Research Center demonstrate how the isolation of exosomes, being a minimally invasive procedure, opens new possibilities for diagnostics.